2022. Cornuside ameliorated experimental autoimmune encephalomyelitis by limiting the recruitment of CD4+ T lymphocytes in the spinal cord. Brazilian Journal of Pharmaceutical Sciences. 58, (Nov. 2022). DOI:https://doi.org/10.1590/s2175-97902022e191070 .